Shares of Boston Scientific jump today after the FDA approves its Watchman anti-stroke device.
Investors sent shares of Boston Scientific (NYSE:BSX) up nearly 4% today after the medical device company said the FDA approved its long-delayed Watchman anti-stroke device.
News Well, Cardiac Implants, Pre-Market Approval (PMA), Regulatory/Compliance, Stroke, Wall Street Beat
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Eqp4Uy
Cap comentari:
Publica un comentari a l'entrada